Citations

Clear

4 citation(s) found for "Chen, Sisi".

Modeling Gut Neuro-Epithelial Connections in a Novel Microfluidic Device
Hoyos‐Vega, José M. de , Yu, Xi , Gonzalez‐Suarez, Alan M. , Mercado‐Perez, Arnaldo , Krueger, Eugene W. , Hernandez, Jeric, Druliner, Brooke R., Chen, Sisi , Fedyshyn, Yaroslav , Revzin, Alexander , de Hoyos-Vega, Jose M , Gonzalez-Suarez, Alan, Krueger, Eugene, Druliner, Brooke , Gonzalez-Suarez, Alan M , Druliner, Brooke R. , Linden, David R. , Beyder, Arthur

Mayo Clinic

No container title available | September 7, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2972828/v1 | PMID 37720014 Get It

Abstract Organs that face external environments, such as skin and gut, are lined by epithelia, which have two functions – to provide a semi-permeable barrier and to sense stimuli. The intestinal lumen is filled with diverse chemical and physical stimuli. Intestinal epithelial cells sense these stimuli and signal to enteric neurons which coordinate a range of physiologic processes required for normal digestive tract function. Yet, the neuro-epithelial connections between intestinal epithelial cells and enteric neurons remain poorly resolved, which leaves us with limited mechanistic understanding of their function. We describe the development of a two-compartment microfluidic device for modeling neuro-epithelial interactions, and apply it to form the gut’s neuro-epithelial connections. The device contains epithelial and neuronal compartments connected by microgrooves. The epithelial compartment was designed for cell seeding via injection and confinement of intestinal epithelial cells derived from human intestinal organoids. We demonstrated that organoids planarized effectively and retained epithelial phenotype for over a week. In the second chamber we dissociated and cultured intestinal myenteric neurons including intrinsic primary afferent neurons (IPANs) from transgenic mice that expressed the fluorescent protein tdTomato. IPANs extended projections into microgrooves, surrounded and frequently made contacts with epithelial cells. The density and directionality of neuronal projections were enhanced by the presence of epithelial cells in the adjacent compartment. Our microfluidic device represents a platform for dissecting structure and function of neuro-epithelial connections in the gut and other organs (skin, lung, bladder, and others) in health and disease.
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
Rahman, Masum , Olson, Ian , Mansour, Moustafa , Carlstrom, Lucas P. , Sutiwisesak, Rujapope , Saber, Rehan, Warrington, Arthur E. , Howard, A. B., Chen, Sisi , Decker, Paul A. , Sananikone, Eliot F., Zhu, Yi , Burma, Sandeep , Kirkland, James L. , Rajani, Karishma , Howard, Adam, Schroeder, Mark, Decker, Paul A. , Parney, Ian F , Brown, Desmond , Sarkaria, Jann N , Kirkland, James L , Burns, Terry C , Zhu, Yi , Mansour, Moustafa A , Schroeder, Mark A. , Tchkonia, Tamar , Parney, Ian F. , Brown, Desmond , Rodriguez, Moses , Sarkaria, Jann N. , Burns, Terry C.

Mayo Clinic

Molecular Cancer Research | June 3, 2022 | Volume: 20 | Issue: 6 | Pages: 938-948

10.1158/1541-7786.mcr-21-0029 | PMID 35191501 Get It

Abstract Glioblastoma (GBM) is a rapidly fatal malignancy typically treated with radiation and temozolomide (TMZ), an alkylating chemotherapeutic. These cytotoxic therapies cause oxidative stress and DNA damage, yielding a senescent-like state of replicative arrest in surviving tumor cells. Unfortunately, recurrence is inevitable and may be driven by surviving tumor cells eventually escaping senescence. A growing number of so-called “senolytic” drugs have been recently identified that are defined by their ability to selectively eliminate senescent cells. A growing inventory of senolytic drugs is under consideration for several diseases associated with aging, inflammation, DNA damage, as well as cancer. Ablation of senescent tumor cells after radiation and chemotherapy could help mitigate recurrence by decreasing the burden of residual tumor cells at risk of recurrence. This strategy has not been previously explored for GBM. We evaluated a panel of 10 previously described senolytic drugs to determine whether any could exhibit selective activity against human GBM persisting after exposure to radiation or TMZ. Three of the 10 drugs have known activity against BCL-XL and preferentially induced apoptosis in radiated or TMZ-treated glioma. This senolytic activity was observed in 12 of 12 human GBM cell lines. Efficacy could not be replicated with BCL-2 inhibition or senolytic agents acting against other putative senolytic targets. Knockdown of BCL-XL decreased survival of radiated GBM cells, whereas knockdown of BCL-2 or BCL-W yielded no senolytic effect. Implications: These findings imply that molecularly heterogeneous GBM lines share selective senescence-induced BCL-XL dependency increase the significance and translational relevance of the senolytic therapy for latent glioma.
Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease
Zheng, Tenghao , Ellinghaus, David , Juzėnas, Simonas , Cossais, François , Burmeister, Greta , Mayr, Gabriele , Jørgensen, Isabella Friis , Teder‐Laving, Maris , Skogholt, Anne Heidi , Chen, Sisi , Strege, Peter R. , Ito, Go , Banasik, Karina , Bokelmann, Frank, Buch, Stephan , Clausnitzer, Hartmut, Degenhardt, Frauke , Doniec, Marek J., Erikstrup, Christian , Förster, Michael , Frey, Norbert , Fritsche, Lars G. , Gabrielsen, Maiken E. , Gräßle, Tobias , Gsur, Andrea , Hampe, Jochen , Hendricks, Alexander , Hinz, Sebastian , Jongen, Johannes , Junker, Ralf, Karlsen, Tom H. , Hemmrich‐Stanisak, Georg , Kruis, Wolfgang , Kupčinskas, Juozas , Laubert, Tilman , Rosenstiel, Philip , Röcken, Christoph , Laudes, Matthias , Leendertz, Fabian H. , Limperger, Verena , Margetis, Nikolaos, Mätz‐Rensing, Kerstin, Németh, Christopher Georg , Ness‐Jensen, Eivind , Nowak‐Göttl, Ulrike, Pandit, Anita , Pedersen, Ole Birger , Peleikis, H.-G., Peuker, Kenneth , Rodríguez, Cristina Leal , Schniewind, Bodo, Schulzky, Martin, Skiecevičienė, Jurgita , Tepel, Jürgen, Thomas, Laurent F. , Uellendahl-Werth, Florian , Ullum, Henrik , Vogel, Ilka, Völzke, Henry , Schönfels, Witigo von , Vanderwerff, Brett , Wilking, Julia, Wittig, Michael , Zeißig, Sebastian , Zobel, Myrko, Zawistowski, Matthew , Vacic, Vladimir, Sazonova, Olga V. , Noblin, Elizabeth S., Farrugia, Gianrico , Kahlke, Volker, Schafmayer, Clemens , D’Amato, Mauro , Datz, Christian , Forster, Michael , Gsur, Andrea , Hampe, Jochen , Röcken, Christoph , Ness-Jensen, Eivind , Rühlemann, Malte Christoph , Farrugia, Gianrico , D'Amato, Mauro , Franke, André , Ellinghaus, David , Zheng, Tenghao , Strege, Peter R , Erikstrup, Christian , Kupcinskas, Juozas , Becker, Thomas S , Brunak, Søren , Esko, Tõnu , Groß, Justus , Hveem, Kristian , Lieb, Wolfgang , Fersen, Lorenzo von , Sazonova, Olga, Beyder, Arthur , Wedel, Thilo

Mayo Clinic

Gut | April 22, 2021 | Volume: 70 | Issue: 8 | Pages: 1538-1549

10.1136/gutjnl-2020-323868 | PMID 33888516 Get It

Objective Haemorrhoidal disease (HEM) affects a large and silently suffering fraction of the population but its aetiology, including suspected genetic predisposition, is poorly understood. We report the first genome-wide association study (GWAS) meta-analysis to identify genetic risk factors for HEM to date. Design We conducted a GWAS meta-analysis of 218 920 patients with HEM and 725 213 controls of European ancestry. Using GWAS summary statistics, we performed multiple genetic correlation analyses between HEM and other traits as well as calculated HEM polygenic risk scores (PRS) and evaluated their translational potential in independent datasets. Using functional annotation of GWAS results, we identified HEM candidate genes, which differential expression and coexpression in HEM tissues were evaluated employing RNA-seq analyses. The localisation of expressed proteins at selected loci was investigated by immunohistochemistry. Results We demonstrate modest heritability and genetic correlation of HEM with several other diseases from the GI, neuroaffective and cardiovascular domains. HEM PRS validated in 180 435 individuals from independent datasets allowed the identification of those at risk and correlated with younger age of onset and recurrent surgery. We identified 102 independent HEM risk loci harbouring genes whose expression is enriched in blood vessels and GI tissues, and in pathways associated with smooth muscles, epithelial and endothelial development and morphogenesis. Network transcriptomic analyses highlighted HEM gene coexpression modules that are relevant to the development and integrity of the musculoskeletal and epidermal systems, and the organisation of the extracellular matrix. Conclusion HEM has a genetic component that predisposes to smooth muscle, epithelial and connective tissue dysfunction.
CBIO-11. NOVEL THERAPY TO TARGET PR-RECURRENT GLIOMA
Olson, Ian , Saber, Rehan, Chen, Sisi , Rahman, Masum , Zhang, Jibo , Carlstrom, Lucas P. , Rajani, Karishma , Brown, Desmond , Parney, Ian F. , Sarkaria, Jann N. , Burns, Terry C.

Mayo Clinic

Neuro-Oncology | December 4, 2020 | Volume: 22 | Issue: Supplement_2 | Pages: ii17-ii18

10.1093/neuonc/noaa215.071 Get It

Abstract BACKGROUND Glioblastoma is a fatal infiltrative primary brain tumor, and standard care includes maximal safe surgical resection followed by radiation and Temozolomide (TMZ). Therapy-resistant residual cells persist in a latent state a long time before inevitable recurrence. Conventional radiation and Temozolomide (TMZ) treatment cause oxidative stress and DNA damage resulting senescent-like state of cell-cycle arrest. However, increasing evidence demonstrates escaping senescence leads to tumor recurrence. Thus, the ablation of senescent tumor cells after chemoradiation may be an avenue to limit tumor recurrence. METHODS 100uM TMZ for 7days or 10-20Gy radiation (cesium gamma radiator) was used for senescence induction in human glioblastoma in vitro and confirmed by SA-Beta gal staining and PCR. Replication arrest assessed by automated quantification of cellular confluence (Thermo Scientific Series 8000 WJ Incubator). We evaluated the IC50 for several senolytics targeting multiple SCAPs, including Dasatinib, Quercetin, AMG-232, Fisetin, Onalespib, Navitoclax, and A1331852, and in senescent vs. proliferating cells. RESULTS Among the senolytic tested, the Bcl-XL inhibitors A1331852 and Navitoclax both shown senolytic effect by selectively killing radiated, senescent tumor cells at lower concentrations as compared to 0Gy treated non-senescent cells. Across 12 GBM cell lines, IC50 for senescent cells was 6–500 times lower than non-senescent GBM(p< 0.005). Such differential sensitivity to Bcl-XL inhibition after radiation has also observed by BCL-XL knockdown in radiated glioma. CONCLUSION These findings suggest the potential to harness radiation-induced biology to ablate surviving quiescent cells and demonstrate Bcl-XL dependency as a potential vulnerability of surviving tumor cells after exposure to chemoradiation.